Abstract
Gene therapy approaches to cancer treatment have been limited by the ability of the delivery vectors to achieve specific high-level expression within tumor cells or the tumor environment following systemic administration. Numerous physical barriers exist in the delivery of therapeutic agents (including drugs, viruses, and liposomes) to solid tumors that can compromise the effectiveness (1), thus stimulating the search for alternative methods of delivery. Whereas it has been known for some time that spores of anaerobic Clostridium can germinate within the necrotic spaces of human tumors, they are limited to larger hypoxic tumors and are inaccessible to smaller metastases (2,3). The ability of motile, facultatively anaerobic Salmonella to target tumors following systemic administration, preferentially amplify within them, and express effector genes such as the herpes simplex virus thymidine kinase (HSV-TK) makes them an attractive alternative to Clostridia, liposome and viral-based delivery vectors (4). These Salmonella were attenuated by poly-auxotrophic mutations, which limited their pathogenesis in normal tissues, but retained high-level replication within tumors, resulting in tumor suppression of both primary and metastatic tumors (4,5). The attenuating mutations were added stepwise following in vitro and in vivo selection and screening methods. Although live-attenuated vectors for use in humans requires defined genetic mutations, our experience has shown that combinations of point-mutations and frame-shift mutations allows for rapid isolation of strains with multiple mutations having desirable properties, which can later be defined and/ or stabilized. Bearing this in mind, we present the basic methodology for the development of tumor-targeting facultative anaerobes with effector gene delivery capabilities that we applied to Salmonella.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jain, R. K. (1994) Barriers to drug delivery in solid tumors. Scient. Am. 271 (July), 58ā65.
Parker, R. C., Plummber, H. C., Siebenmann, C. O., and Chapman, M. G. (1947) Effect of histolyticus infection and toxin on transplantable mouse tumors. Proc. Soc. Exp. Biol. Med. 66, 461ā465.
Fox, M. E., Lemmon, M. J., Mauchline, M. L., Davis, T. O., Giaccia, A. J., Minton, N. P., and Brown, J. M. (1996) Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther. 3, 173ā178.
Pawelek, J. M., Low, K. B., and Bermudes, D. (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57, 4537ā4544.
Zheng, L. M., Luo, X., Fischer, J., Le, T., Bermudes, D., Low, B., et al. (1997) Attenuated Salmonella typhimurium inhibited tumor metastasis in vivo. Proc. Amer. Asoc. Cancer Res. (abstrt.) 38, 9.
Bacon, G. A., Burrows, T. W., and Yates, M. (1950) The effects of biochemical mutation on the virulence of bacterium typhosum: the induction and isolation of mutants. Br. J. Exp. Path. 31, 703ā713.
Bacon, G. A., Burrows T. W., and Yates, M. (1951) The effects of biochemical mutation on the birulence of bacterium typhosum: the loss of virulence of certain mutants. Br. J. Exp. Path. 32, 85ā96.
Hoiseth, S. K. J. and Stocker, B. A. D. (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238ā239.
OāCallaghan, D., Maskell, D., Liew, F. Y., Easmon, C. S. F., and Dougan, G. (1988) Characterization of aromatic-and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability induce protective immunity in BALB/c mice. Infect. Immun. 56, 419ā423.
Pidherney, M. S., Alizadeh, H., Steward, G. L., McCulley, J. P., and Niederkorn, J. Y. (1993) In vitro and in vivo tumorcidal properties of a pathogenic/free-living amoeba. Cancer Lett. 72, 91ā98.
Alizadeh, H., Pidherney, M. S., McCulley, J. P., and Niederkorn, J. Y. (1994) Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living amoeba. Infect. Immun. 62, 1298ā1303.
Miller, J. H. (1992) A Short Course in Bacterial Genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor.
Hutchinson, F. (1996) Mutagenesis, in Escherichia coli and Salmonella typhimurium, Cellular and Molecular Biology (Neidhardt, F. C., Curtiss III, R., Ingraham, J. L., Lin, E. C. C., Low, K. B., Magasanik, B., et al., eds.), Am. Soc. Microbiol., Washington, DC, pp. 2218ā2235.
Cunningham, C. C., Gorlin, J. B., Kwiatkowski, D. J., Hartwig, H. J., Janmey, P. A., Byers, H. R., and Stossel, T. P. (1992) Actin-binding protein requirement for cortical stability and efficient locomotion. Science 255, 325ā327.
Vile, R. G. and Hart, I. R. (1993) Use of tissue-specific expression of the herpes simples virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res. 53, 3860ā3864.
Moolten, F. L. and Wells, J. M. (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297ā300.
Talmadge, K,. Stahl, S., and Gilbert, W. (1980) Eukaryotic signal sequence transports insulin antigen in Escherchia coli. Proc. Natl. Acad. Set USA 77, 3369ā3373.
Pugsley, A. P. (1988) Protein secretion across the outer membrane of gram-negative bacteria, in Protein Transfer and Organelle Biogenesis (Das, R. C. and Robbins, P. W., eds.), Academic, New York, pp. 607ā652.
Holland, I. B., Wang, R., Seror, S. J., and Blight, M. (1989) Haemolysin secretion and other protein translocation mechanisms in gram-negative bacteria, in Microbial Products, New Approaches (Baumberg, S., Hinster, I., and Rhodes, M., eds.), Cambridge University Press, Cambridge, pp. 219ā254.
Wagner, W., Vogel, M. l., and Goebel, W. (1983) Transport of haemolysin across the outermembrane of Escherichia coli requires two functions. J. Bacteriol. 154, 200ā210.
Su, G-F., Brahmbhatt, H. N., deLorenzo, V., Wehland, J., and Timmis, K. N. (1992) Extracellular export of shiga toxin B-subunit/haemolysin A (C-terminus) fusion protein expressed in Salmonella typhimurium aroA-mutant and stimulation of B-subunit specific antibody responses in mice. Microbial. Pathogenesis 13, 465ā476.
Jones, J. D. G., Grady, K. L., Suslow, T. V., and Bedbrook, J. R. (1986) Isolation and characterization of genes encoding two chitinase enzymes from Serratia marcescens. EMBO J. 5, 2377ā2383.
Goebel, W., Hacker, J., Knapp, S., Then, J., Wagner, W., Hughes, C., and Juarez, A. (1984) Structure, function and regulation of the plasmid-encoded hemolysin determinant of E. coli, in Plasmids in Bacteria (Helinski, D. R., Cohen, S. N., Cloewell, D. B., Jackson, D. A., and Hollaender, A., eds.), Plenum, New York, pp. 791ā805.
GuzmĆ”n-Verduzco, L. M., Fonseca, R., and Kaperszotch-Portnoy, Y. M. (1983) Thermoactivation of a periplasmic heat-stable enterotoxin of Escherichia coli. J. Bacteriol. 154, 146ā151.
So, M. and McCarthy, B. T. (1980) Nucleotide sequence of the bacterial transposon Tn1681 encoding a heat-stable (ST) toxin and its identification in enterotoxigenic coli strains. Proc. Natl. Acad. Sci. USA 77, 4011ā4015.
Chapon, C. and Raibaud, O. (1985) Structure of two divergent promoters located in front of the gene encoding pullulanase in Klebsiella pneumoniae and positively reguylated by the malT. product. J. Bacteriol. 164, 639ā645.
dāEnfert, C., Ryter, A., and Pugsely, A. P. (1987) Cloning and expression in Escherichia coli of the Klebsiella pneumoniue genes for production, surface localization and secretion of the lipoprotein pullanase. EMBO J. 6, 3531ā3538.
Yanigida, N., Ouozumi, T., and Beppu, T. (1986) Specific excretion of Serratia marcescens protease through the outer membrane of Escherichia coli. J. Bacteriol. 166, 937ā944.
Collmer, A., Schoedel, C., Roeder, D. L., Ried, J. L., and Rissler, J. F. (1985) Molecular cloning in Escherichia coli of Erwinia chrysanthemi genes encoding multiple forms of pectate lyase. J. Bacteriol. 161, 913ā920.
Keen, N.T., Dahlbreck, D., Staskawicz, B., and Belser, W. (1984) Molecular cloning of pectate lyase genes from Erwinia chrysanthemi and their expression in Escherichia coli. J. Bacteriol. 159, 825ā831.
Lei, S.-P., Lin, H.-C., Hefferman, L., and Wilcox, G. (1985) Cloning of the pectate lyase genes from Erwinia carotovora and their expression in Escherichia coli. Gene 35, 63ā70.
Zink, R.T. and Chatterjee, A.K. (1985) Cloning and expression in Escherichia coli of pectinase gene of Erwinia carotovora subsp. carotovora. Appl. Environ. Microbiol. 49, 714ā717.
Barras, F., Thurn, K. K., and Chatterjee, A. K. (1986) Export of Erwinia chrysanthemi (EC16) protease by Escherichia coli. FEMS Microbiol. Lett. 34, 343ā348.
Elsinghorst, E. A. (1994) Measurement of invasion by gentamycin resistance. Meth. Enzymol. 236, 405ā420.
Lee, C. A. and Falkow, S. (1994) Isolation of hyperinvasive mutants of Salmonella. Meth. Enzymol. 236, 531ā545.
Reed, L., J. and Muench, H. (1938) A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493ā497.
Welkos, S. and OāBrien, A. (1994) Determination of median lethal and infectious doses in animal model systems. Meth. Enzymol. 235, 29ā39.
Bonnekoh B., Greenhalgh, D. A., Bundman, D. S., Ekhardt, J. N., Longley, M. A., Chen., S. H., et al. (1995) Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene tranfer in vivo. J. Invest. Derm. 104, 313ā317.
King, I., Feng, M., Lou, X., Lin, S., Bermudes, D., and Zheng, L.-M. (1998) Tumor-targeted Salmonella expressing cytosine deaminase converted 5-fluorocytosine to 5-fluorouricil and inhibited tumor growth in vivo. Ann. Meet. Am. Assoc. Cancer Res., New Orleans, LA, March 28 to April 2, (abstr.).
Liljeqvist, S., Haddad, D., Berzins, K., UhlĆ©n, M., and StĆ„hl, S. (1996) A novel expression system for Salmonella typhimurium allowing high production levels, product secretion and efficient recovery. Biochem. Biophys. Res. Comm. 218, 356ā359.
McKnight, S.L. (1980) The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nuc. Acids. Res. 8, 5949ā5964.
Wagner, M..J., Sharp, J.A., and Summers, W.C. (1981) Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 78, 1441ā1445.
OāCallaghan, D. and Charbit, A. (1990) High efficiency transformation of Salmonella typhimurium and Salmonella typhi by electroporation. Mol. Gen. Genet. 223, 156ā158.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor, Cold Spring Harbor.
Summers, W. C. and Summers, W. P. (1977) [125I]deoxycytidine used in a rapid, sensitive, and specific assay for herpes simplex virus type 1 thymidine kinase. J. Virol. 24, 314ā318.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Bermudes, D., Low, B., Pawelek, J.M. (2000). Tumor-Targeted Salmonella: Strain Development and Expression of the HSV-tK Effector Gene . In: Walther, W., Stein, U. (eds) Gene Therapy of Cancer. Methods in Molecular Medicineā¢, vol 35. Humana Press. https://doi.org/10.1385/1-59259-086-1:419
Download citation
DOI: https://doi.org/10.1385/1-59259-086-1:419
Publisher Name: Humana Press
Print ISBN: 978-0-89603-714-4
Online ISBN: 978-1-59259-086-5
eBook Packages: Springer Protocols